NCT04202952View on ClinicalTrials.gov

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

August 27, 2020

Study Completion Date

August 27, 2020

Conditions

Chronic Hepatitis C

Interventions

DRUG

HEC110114 Tablet

administered orally once daily

DRUG

Sofosbuvir Tablet

administered orally once daily

Trial Locations (1)

130021

The First Hospital of Jilin University, Jilin

All Listed Sponsors

lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT04202952 - The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects | Biotech Hunter | Biotech Hunter